Phenylacetylglycine, a putative biomarker of phospholipidosis: Its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model

References

• ALVAREZ, D. L., CAMPISTOL, P. J., RIBES, R. A. and RIVEROLA DE VECINA, A. T. 1992, Phenylalanine metabolites in hyperphenylalaninaemic children. Anales Espanoles de Pediatria, 36, 371–374.
   Google Scholar
• ASAOKA, K 1991, Enzymes that metabolize acyl-coenzyme A in the monkey — their distribution, properties and roles in an alternative pathway for the excretion of nitrogen. International Journal of Biochemistry, 23, 429–434.
   PubMedGoogle Scholar
• AYLING, J., PIRSON, R, PIRSON, W. and BOEHM, G. 1973, A specific kinetic assay for phenylalanine hydroxylase. Analytical Biochemistry, 51, 80–90.
   PubMed Web of Science ®Google Scholar
• BARGAL, R. and BACH, G. 1988, Phospholipids accumulation in mucolipidosis IV cultured fibroblasts. Journal of Inherited Metabolic Disease, 11, 144–150.
   PubMedGoogle Scholar
• BERDEAUX, A., ROCHE, A., LABAILLE, T, GIROUX, B., EDOUARD, A. and GUIDICELLI, J. F. 1984, Tissue extraction of amiodarone and N-desethylamiodarone in man after a single oral dose. British Journal of Clinical Pharmacology, 18, 759–763.
   PubMedGoogle Scholar
• BURKE, M. D., THOMPSON, S., WEAVER, R J., WOLF, C. R and MAYER, R T. 1994, Cytochrome P450 specificities of alkoxyresorufin 0-dealkylation in human and rat liver. Biochemical Pharmacology, 48, 923–936.
   PubMed Web of Science ®Google Scholar
• CHrrwooD, K. K, ABDUL-HAQQ, A. J. and HEim-DuTHoy, K L 1993, Cyclosporine-amiodarone interaction. Annals of Pharmacotherapy, 27, 569–571.
   Google Scholar
• COCHRAN, F. R, RODDICK, V. L., CONNOR, J. R, THORNBURG, J. T. and WAITE, M. 1987, Regulation of arachadonic acid metabolism in resident and BCG-activated alveolar macrophages: role of lyso(bis)phosphatidic acid. Journal of Immunology, 138, 1877–1883.
   PubMedGoogle Scholar
• CUMMINGS, J. H., POMARE, E. W, BRANCH, W. J., NAYLOR, C. P. E. and MCFARLANE, G. T. 1987, Short chain fatty acids in the human large intestine, portal, hepatic and venous blood. Gut, 28, 1221–1227.
   Google Scholar
• CUMMINGS, J. H. 1995, Short chain fatty acids. In Human Colonic Bacteria: Role in Nutrition, Physiology and Pathology, edited by G. R. Gibson and G. T. MacFarlane (Boca Raton: CRC Press), pp. 101–130.
   Google Scholar
• DAKE, M. D., MADISON, J. M., MONTGOMERY, C. K, SHEillTo, J. E., HINCHCLIFFE, W. A., WINKLER, M. L. and BAINTON, D. F. 1985, Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes and blood leukocytes of patients with amiodarone pulmonary toxicity. American Journal of Medicine, 78, 506–512.
   PubMed Web of Science ®Google Scholar
• Ell-EDER, M. 1989, Niemann—Pick disease. Pathology, Research and Practice, 185, 293–328.
   PubMedGoogle Scholar
• ERLANDSEN, H. and STEVENS, R. C. 1999, The structural basis of phenylketonuria. Molecular Genetics and Metabolism, 68, 103–125.
   PubMed Web of Science ®Google Scholar
• ESPINA, J. R., SHOCKCOR, J. P., HERRON, W. J., CAR, B. D., CONTEL, N. R., CIACCIO, P. J., LINDON, J. C., HOLIVIES, E. and NICHOLSON, J. K. 2001, Net action of in vivo biomarkers of phospholipidosis using NMR-based metabonomic approaches. Magnetic Resonance in Chemistry, 39, 559–565.
   Web of Science ®Google Scholar
• FOWLER, S. D., BROWN, W. J., WARFEL, J. and GREENSPAN, P. 1987, Use of Nile red for the rapid in situ quantitation of lipids on thin-layer chromatograms. Journal of Lipid Research, 28, 1225–1232.
   PubMedGoogle Scholar
• FREDMAN, P., KLINGHARDT, G. W, NILSSON, 0. and SVENNERHOLM, L. 1982, Lipid accumulation in liver, spleen, lungs and kidneys of miniature-pigs after chloroquine treatment. Biochemical Journal, 201, 581–588.
   Google Scholar
• FRUNCILLO, R. J., BERNHARD, R., SWANSON, B. N., VLASSES, P. H. and FERGUSON, R. K 1985, Effect of phenobarbitone on the pharmacokinetics and tissue levels of amiodarone in the rat. Journal of Pharmacy and Pharmacology, 37, 729–731.
   PubMedGoogle Scholar
• HA, H. R, BIGLER, L., BINDER, M., KOZLIC, P., STIEGER, B., HESSE, M., ALTORFER, H. R and FoLEATH, F. 2001, Metabolism of amiodarone (Part I): Identification of a new hydroxylated metabolite of amiodarone. Drug Metabolism and Disposition, 29, 152–158.
   PubMed Web of Science ®Google Scholar
• HA, H. R, CANDINAS, R., STIEGER, B., MEYER, U. A. and FOLLATH, F. 1996, Interaction between amiodarone and lidocaine. Journal of Cardiovascular Pharmacology, 28, 533–539.
   PubMedGoogle Scholar
• HANLEY, W. B., LEE, A. W., HANLEY, A. J., LEHOTAY, D. C., AUSTIN, V. J., SCHOONHEYT, W. E., PLATT, B. A. and CLARKE, J. T. 2000, 'Hypotyrosinaemia' in phenylketonuria. Molecular Genetics and Metabolism, 69, 286–294.
   PubMedGoogle Scholar
• HARRIS, L., HIND, C. R K., MCKENNA, W. J., SAVAGE, C., KRIKLER, S. J., STOREY, G. C. A. and HOLT, D. W. 1983, Renal elimination of amiodarone and its desethyl metabolite. Postgraduate Medical Journal, 59, 440–442.
   Google Scholar
• HOLT, D. W, TUCKER, G. T., JACKSON, P. R and STOREY, G. C. A. 1983, Amiodarone pharmacokinetics. American Heart Journal, 106, 840–847.
   PubMed Web of Science ®Google Scholar
• HooK, G. E. 1991, Alveolar proteinosis and phospholipidoses of the lungs. Toxicologic Pathology, 19, 482–513.
   PubMed Web of Science ®Google Scholar
• JAMES, M. 0. and BEND, J. R. 1978, A radiochemical assay for glycine N-acyltransferase activity. Some properties of the enzyme in rat and rabbit. Biochemical Journal, 172, 285–291.
   Google Scholar
• JAMES, M. 0., SMITH, R L, WILLIAMS, R. T. and REIDENBERG, M. 1972, The conjugation of phenylacetic acid in man, sub-human primates and some non-primate species. Proceedings of the Royal Society London B, 182, 25–35.
   Google Scholar
• JANKOWSKI, J., LUFTMANN, H., TEPEL, M., LEIBRITZ, D., ZLDEK, W. and SCLUTER, H. 1998, Characterisation of dimethylguanosine, phenylethylamine, and phenylacetic acid as inhibitors of Ca2+ ATPase in end-stage renal failure. Journal of the American Society of Nephrology, 9, 1249–1257.
   PubMedGoogle Scholar
• JONES, C. R., GUENGERICH, F. P., RICE, J. M. and LUBET, R. A. 1992, Induction of various cytochromes CYP2B, CYP2C and CYP3A by phenobarbitone in non-human primates. Pharmacogenetks, 2, 160–172.
   PubMedGoogle Scholar
• KHAN, R. I., ONODERA, R, AMIN, M. R and MOHAMMED, N. 1999, Production of tyrosine and other aromatic compounds from phenylalanine by rumen microorganisms. Amino Acids, 17, 335-346. KODOVANTI, U. P. and MEHENDALE, H. M. 1990, Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacological Reviews, 42, 327–354.
   Google Scholar
• KOZLIC, P., HA, H. R., STIEGER, B., BIGLER, Land FOLLATH, F. 2001, Metabolism of amiodarone (Part III): Identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodarone. Xenobiotica, 31, 239–248.
   PubMedGoogle Scholar
• LIBERSA, C. C., BRIQUE, S. A., MoTTE, K B., CARON, J. F., GUEDON-MOREAU, L. M., HUMBERT, L.,
   Google Scholar
• VINCENT, A., DEVOS, P. and LHERNuTrE, M. A. 2000, Dramatic inhibition of amiodarone metabolism induced by grapefruit juice. British Journal of Clinical Pharmacology, 49, 373-378. MARCUS, F. I. 1983, Drug interactions with amiodarone. American Heart Journal, 106, 924–930.
   Google Scholar
• MARTIN-ALGARRA, R V., PASCUAL-COSTA, R M., MERINO, M. and CASABO, V. G. 1994, Effects of surfactants on amiodarone intestinal absorption. I. Sodium laurylsulphate. Pharmaceutical Research, 11, 1042–1047.
   Google Scholar
• MARTIN-ALGARRA, R V., PASCUAL-COSTA, R M., MERINO, M. and CASABO, V. G. 1995, Effects of polysorbate 80 on amiodarone intestinal absorption in the rat. International Journal of Pharmaceutics, 122, 1–8.
   Google Scholar
• MAZUE, G., Vic, P., GOUY, D., REMANDET, B., LACHERETZ, F., BERTHE, J., BARCHEWITZ, G. and GAGNOL, J. P. 1984, Recovery from amiodarone-induced lipidosis in laboratory animals: a toxicological study. Fundamental and Applied Toxicology, 4, 992–999.
   PubMedGoogle Scholar
• MICHALS, K. and MATALON, R. 1985, Phenylalanine metabolites, attention span and hyperactivity. American Journal of Clinical Nutrition, 42, 361–365.
   PubMedGoogle Scholar
• MomAvE, K and MEISTER, A. 1957, Synthesis of phenylacetylglutamine by human tissue. Journal of Biological Chemistry, 229, 463–476.
   PubMedGoogle Scholar
• Moss, D. W, HENDERSON, M. B. and KACHMAR, J. F. 1987, Enzymes. In Fundamentals of Clinical Chemistry, edited by N. W. Tietz, 3rd edn (Philadelphia: W. B. Saunders), p. 12 (ch. 12).
   Google Scholar
• NAKASHIMA, S., NAGATA, K, BANNO, Y., SAKIYAMA, T., KITAGAWA, T, MIYAWAKI, S. and NOZAWA, Y. 1984, A mouse model for Niemann—Pick disease: phospholipid class and fatty acid composition of various tissues. Journal of Lipid Research, 25, 219–227.
   PubMedGoogle Scholar
• NicHou_s, A. W, MORTISHIRE-SMITH, R. J. and NICHOLSON, J. K 2003, NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatising germ-free rats. Chemical Research in Toxicology, 16, 1395–1404.
   Google Scholar
• NicHou_s, A. W, NICHOLSON, J. K, HASEIDEN, J. N. and WATERFIEED, C. J. 2000, A metabonomic approach to the investigation of drug-induced phospholipidosis: an NMR spectroscopy and pattern recognition study. Biomarkers, 5, 410–423.
   Google Scholar
• OMURA, T. and SATO, R 1964, The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its haemoprotein nature. Journal of Biological Chemistry, 239, 2370–2378.
   Google Scholar
• PAKUTS, A. P., PARKS, R J., PAUL, C. J., BUJAKI, S. J. and MUELLER, R W. 1990, Ketoconazole-induced hepatic lysosomal phospholipidosis: the effect of concurrent barbiturate treatment. Research Communications in Chemical Pathology and Pharmacology, 67, 55–62.
   PubMedGoogle Scholar
• PETRUSCHKA, L., REBRIN, I., GRINIM, U. and HERRMANN, F. H. 1990, The immunological evidence for a phenylalanine hydroxylase like immunoreactive protein in different human cells and tissues. Clinica et Chimica Acta, 193, 65–78.
   PubMedGoogle Scholar
• PHipps, A. N., STEWART, J., WRIGHT, B. and WILSON, I. D. 1998, Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica, 28, 527–537.
   PubMed Web of Science ®Google Scholar
• REASOR, M. J. and DAVIS, M. E. 1985, Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital. Drug Metabolism and Disposition, 13, 192–196.
   PubMed Web of Science ®Google Scholar
• REASOR, M. J., McCEoup, C. M., BEARD, T. L., EBERT, D. C., KACEW, S., GARDNER, M. F., ALDERN, K A. and HosTETLER, K Y. 1996, Comparative evaluation of amiodarone-induced phospho-lipidosis and drug accumulation in Fischer-344 and Sprague—Dawley rats. Toxicology, 106, 139–147.
   PubMed Web of Science ®Google Scholar
• REASOR, M. J., OGLE, C. L., WALKER, E. R. and KACEW, S. 1988, Amiodarone-induced phospholipidosis in rat alveolar macrophages. American Review of Respiratory Disease, 137, 510–518.
   PubMed Web of Science ®Google Scholar
• REMESY, C. and DEMIGNE, C. 1976, Partition and absorption of volatile fatty acids in the alimentary canal of the rat. Annales de Recherches Veterinaires, 7, 39–55.
   PubMedGoogle Scholar
• SCHULPIS, K. H., TJAMOURANIS, J., KARLKAS, G. A., MICHELAKAKIS, H. and TSAKIRI SS. 2002, In vivo effects of high phenylalanine blood levels on Na, K+ -ATPase, Mg2+ -ATPase activities and biogenic amine concentrations in phenylketonuria. Clinical Biochemistry, 35, 281–285.
   PubMedGoogle Scholar
• ScHuLz, T. G., THIEL, R., NEUBERT, D., BRASSIL, P. J., ScHuLz-UTERmonxi_, T., Booms, A. R and EDWARDS, R. J. 2001, Assessment of P450 induction in the marmoset monkey using targeted anti-peptide antibodies. Biochimica et Biophysica Acta, 1546, 143–155.
   Google Scholar
• SEAKINS, J. W. T. 1971, the determination of urinary phenylacetylglutamine as phenylacetic acid. Studies on its origins in normal subjects and children with cystic fibrosis. Clinica Chimica Acta, 35, 121–131.
   PubMedGoogle Scholar
• SIMENHOFF, M., SAUKKONEN, J., SCHAEDLER, R., GORDON, S. and BURKE, J. 1974, Amine metabolism and the small intestinal flora in uraemia. Clinical Science and Molecular Medicine, 46, 23.
   Google Scholar
• SIRAJUDEEN, K N. S., SEI-VI, R. T., BABAKRISHAN, DEVARAJ, H. and DEVARAJ, N. S. 2000, Effect of amiodarone on membrane bound enzymes of rat intestine. Drug and Chemical Toxicology, 23, 387–400.
   Google Scholar
• SNirrx, E. A. and MACFARLANE, G. T. 1996, Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. Journal of Applied Bacteriology, 81, 288–302.
   PubMedGoogle Scholar
• SNirrx, E. A. and IVIAcFARLANE, G. T 1997, Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microbial Ecology, 33, 180–188.
   PubMedGoogle Scholar
• TRONG, H. B., LEPTHIN, J. and DEBUC HH. 1978, Lysosomal phospholipids from rat liver after treatment with different drugs. Hoppe-Seylers Zeitschrift fur Physiologische Chemk, 359, 63–67.
   PubMedGoogle Scholar
• TIUVIER, J.-M., LIBERSA, C., BELLOC, C. and LHERAurrE, M. 1993, Amiodarone N-deethylation in human liver microsomes: involvement of cytochrome P4503A enzymes (First report). Life Sciences, 52, 91–96.
   Google Scholar
• VAN DER HEIDEN, C., WADMAN, S. K., KErriNG, D. and DE BREE, P. K 1971a, Urinary and faecal excretion of metabolites of tyrosine and phenylalanine in a patient with cystic fibrosis and severely impaired amino acid absorption. Clinica Chimica Acta, 31, 133–141.
   PubMedGoogle Scholar
• VAN DER HEIDEN, C., WAUTERS, E. A. K., KETTING, D., Dui, M. and WADMAN, S. K 1971b, Gas chromatographic analysis of urinary tyrosine and phenylalanine metabolites in patients with gastrointestinal disorders. Clinica Chimica Acta, 34, 289–296.
   Google Scholar
• WADMAN, S. K, VAN DER HEIDEN, C., KETTING, D. and VAN SPRANG, F. J. 1971, Abnormal tyrosine and phenylalanine metabolism in patients tyrosyluria and phenylketonuria: gas—liquid chromato-graphic analysis of urinary metabolites. Clinica et Chimica Acta, 34, 277–287.
   Google Scholar
• WATERS, P. J., PARNIAK, M. A., NOWACKI, P. and SCIUVER, C. R. 1998, In vitro expression analysis of mutations in phenylalanine hydroxylase: linking genotype to phenotype and structure to function. Human Mutation, 11, 4–17.
   PubMedGoogle Scholar
• WEAVER, R. J., THOMPSON, S., SMITH, G., DICKENS, M., EICOMBE, C. R, MAYER, R T. and BURKE, M. D. 1994, A comparative study of constitutive and induced alkoxyresorufin 0-dealkylation and individual cytochrome P450 forms in cynomolgous monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes. Biochemical Pharmacology, 47, 763–773.
   PubMed Web of Science ®Google Scholar
• WEBSTER, L T., SIDDIQUI, U. A., LUCAS, S. V, STRONG, J. M. and MIEYAL, J. J. 1976, Identification of separate acyl-coA:glycine and acyl-coA:glutamine N-acyltransferase activities in mitochondrial fractions from liver of rhesus monkey and man. Journal Biological Chemistry, 251, 3352–3358.
   PubMed Web of Science ®Google Scholar
• WOOLF, L. I. 1951, Excretion of conjugated phenylacetic acid in phenylketonuria. Biochemical Journal, 49, ix—x.
   Google Scholar
• YAMAMOTO, A., ADACHI, S., KITANI, T., SHINJI, Y., SEKI, K., NASTJ, T. and NISHIKAWA, M. 1971, Drug-induced lipidosis in human cases and in animal experiments. Journal of Biochemistry, 69, 613–615.
   PubMed Web of Science ®Google Scholar
• YOUNG, G. A. and PARSONS, F. M. 1973, Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clinical Science, 45, 89–97.
   PubMedGoogle Scholar
• YOUNG, R A. and MEHENDALE, H. M. 1987, Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit. Drug Metabolism and Disposition, 15, 511–517.
   PubMed Web of Science ®Google Scholar
• ZIMMERMAN, L., EGESTAD, B., JORNVAII-, H. and BERGSTROM, J. 1989, Identification and determina-tion of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uraemic patients. Clinical Nephrology, 32, 124–128.
   PubMedGoogle Scholar